BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2161122)

  • 1. Sarcoidosis and infections by human lymphotropic viruses.
    Rottoli P; Bianchi Bandinelli ML; Rottoli L; Zazzi M; Panzardi G; Valensin PE
    Sarcoidosis; 1990 Mar; 7(1):31-3. PubMed ID: 2161122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis.
    Musiani M; Zerbini ML; Muscari A; Puddu GM; Gentilomi G; Gibellini D; Gallinella G; Puddu P; La Placa M
    Microbiologica; 1990 Jan; 13(1):35-41. PubMed ID: 2155375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
    Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunoassay of IgM antibodies in samples clinically suspected of measles].
    Ribas Antúnez MA; Arocha Rosete Y; Toraño Canto I; Rodríguez Valdés C
    Rev Cubana Med Trop; 1998; 50(2):105-9. PubMed ID: 10349427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndrome.
    Origgi L; Hu C; Bertetti E; Asero R; D'Agostino P; Radelli L; Riboldi P
    Boll Ist Sieroter Milan; 1988; 67(4):265-74. PubMed ID: 2856043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis.
    Byrne EB; Evans AS; Fouts DW; Israel HL
    Am J Epidemiol; 1973 May; 97(5):355-63. PubMed ID: 4349694
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral antibodies and chronic liver disease.
    Scott BB; Hambling MH; Losowsky MS
    Biomedicine; 1976 Jul; 25(5):163-7. PubMed ID: 187261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of a demographic method for the study of adenoviruses and herpesviruses in a closed infantile community (author's transl)].
    Holý J; Pavlík Z; Vanĕcek K; Zborilová J
    Rev Epidemiol Med Soc Sante Publique; 1975 Sep; 23(6):359-71. PubMed ID: 176843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against herpesviruses in patients with Hodgkin's disease.
    Wutzler P; Färber I; Sprössig M; Sauerbrei A; Wutke K; Höche D; Rüdiger KD; Wöckel W; Scheibner K
    Arch Geschwulstforsch; 1983; 53(5):417-22. PubMed ID: 6316868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral antibody titers are influenced by HLA-DR2 phenotype.
    Lio D; Caccamo N; D'Anna C; Cigna D; Candore G; Caruso C
    Exp Clin Immunogenet; 1994; 11(4):182-6. PubMed ID: 7857663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.
    Rocchi G; Tosato G; Papa G; Ragona G
    Int J Cancer; 1975 Aug; 16(2):323-8. PubMed ID: 168161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of antibodies against herpes simplex virus, Epstein-Barr virus and cytomegalovirus in a group of patients after hemodialysis].
    Resik S; Enamorado A; Tallo Y; Suárez C; Kourí V; Acosta B; García S
    Rev Cubana Med Trop; 1999; 51(3):172-6. PubMed ID: 10887583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age distribution of Epstein-Barr virus, cytomegalovirus and rubella virus antibodies.
    Lin KH; Chiang CH; Yang CS
    Taiwan Yi Xue Hui Za Zhi; 1987 Dec; 86(12):1316-9. PubMed ID: 2832515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Late radiation effects of low doses from occupational exposure. Antibodies to cytomegalovirus, Epstein-Barr virus and human T cell lymphotropic virus type 1 in radiological technologists].
    Kumagai E; Tanoue S; Sawada S
    Rinsho Byori; 1989 May; 37(5):577-83. PubMed ID: 2549288
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of Cytomegalovirus, Epstein-Barr virus and Herpesvirus hominis (types 1 and 2) antibody in institutionalized and non-institutionalized children.
    McMillan BC; Golubjatnikov R; Hanson RP; Sinha SK
    Health Lab Sci; 1977 Oct; 14(4):261-8. PubMed ID: 199558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the precipitation reaction for studying viral antibodies in blood sera].
    Chebotarev VV; Chepulis SS
    Lab Delo; 1979; (8):488-91. PubMed ID: 89261
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
    Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
    Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients.
    Robinson-Agramonte M; Reiber H; Cabrera-Gomez JA; Galvizu R
    Acta Neurol Scand; 2007 May; 115(5):312-8. PubMed ID: 17489941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.